Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT02303821 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
141
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen

Collaborators